Welcome to LookChem.com Sign In|Join Free
  • or
Acetic acid, [4-(trifluoromethyl)cyclohexylidene]-, ethyl ester is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

803736-45-0

Post Buying Request

803736-45-0 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

803736-45-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 803736-45-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,0,3,7,3 and 6 respectively; the second part has 2 digits, 4 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 803736-45:
(8*8)+(7*0)+(6*3)+(5*7)+(4*3)+(3*6)+(2*4)+(1*5)=160
160 % 10 = 0
So 803736-45-0 is a valid CAS Registry Number.

803736-45-0Relevant academic research and scientific papers

Nitrogen-containing bicyclic compounds and preparation method and use thereof

-

Paragraph 0658; 0660-0661, (2018/11/04)

The present invention relates to nitrogen-containing bicyclic compounds and a preparation method and use thereof. The compounds or pharmaceutical compositions can be used as an inhibitor of retinoic acid-related orphan receptor gamma t (ROR gamma t). The invention also relates to the preparation method of the compounds and pharmaceutical compositions, and use of the in the compounds and pharmaceutical compositions in treatment or prevention of RORyt-mediated inflammatation or autoimmune diseases in mammals, particularly humans.

Aryl alkynyl hydrocarbon compound and preparation method and application thereof

-

Paragraph 0492; 0493, (2017/02/17)

The invention relates to an aryl alkynyl hydrocarbon compound and a medicine compound containing the compound. The compound or the medicine compound can serve as an inhibitor of Retinoid-related orphan receptor gamma t (RORyt). The invention further relates to a method for preparing the compound and the medicine compound and application thereof to mammal treatment or prevention, especially RORyt mediated inflammation of humans or autoimmune diseases.

NEW P2X7 RECEPTOR ANTAGONISTS AND THEIR USE

-

Page 76-77, (2008/06/13)

The invention provides compounds of formula (IA), processes for their preparation, pharmaceutical compositions containing them, and their use in therapy. [Chemical formula should be inserted here. Please see paper copy] (IA)

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 803736-45-0